Martin A, Hopewell R, Martín-Sanz P, Morgan J E, Brindley D N
Biochim Biophys Acta. 1986 May 21;876(3):581-91. doi: 10.1016/0005-2760(86)90047-0.
Glycerolipid synthesis was studied in isolated hepatocytes by using 177 microM [14C]oleate and 1 mM [3H]glycerol. Chlorpromazine (25-400 microM) inhibited the synthesis of phosphatidylcholine and triacylglycerol. This was accompanied by an average increase of 12-fold in the accumulation of the labelled precursors in phosphatidate at 200 microM chlorpromazine and a decrease in the conversion of phosphatidate to diacylglycerol of 76%. These results indicate that part of the inhibition of the synthesis of phosphatidylcholine and triacylglycerol occurs at the level of phosphatidate phosphohydrolase. The relative rate of triacylglycerol synthesis at different concentrations of chlorpromazine was approximately proportional to the rate of conversion of phosphatidate to diacylglycerol. Phosphatidylcholine synthesis increased at higher rates of conversion of phosphatidate to diacylglycerol, but it was relatively independent of the latter rate when this was inhibited by more than about 30% with chlorpromazine. The addition of oleate to the hepatocytes caused a translocation of phosphatidate phosphohydrolase from the cytosol to the membrane-associated compartment. Chlorpromazine had the opposite effect and displaced the phosphohydrolase from the membranes in the presence or absence of oleate. There was a highly significant correlation between the activity of phosphatidate phosphohydrolase that was associated with the membranes of the hepatocytes and the calculated conversion of [3H]phosphatidate to diacylglycerol. Chlorpromazine also antagonized the association of the phosphohydrolase with microsomal membranes when cell-free preparations were incubated with combinations of oleate and spermine. Furthermore, it inhibited the transfer of the soluble phosphohydrolase to microsomal membranes that were labelled with [14C]phosphatidate and thereby decreased diacylglycerol production. It is concluded that part of the action of chlorpromazine in inhibiting the synthesis of triacylglycerol and phosphatidylcholine occurs because it prevents the interaction of the soluble phosphatidate phosphohydrolase with the membranes on which glycerolipid synthesis occurs. This in turn prevents the conversion of phosphatidate to diacylglycerol.
利用177微摩尔[14C]油酸酯和1毫摩尔[3H]甘油,在分离的肝细胞中研究了甘油脂质合成。氯丙嗪(25 - 400微摩尔)抑制磷脂酰胆碱和三酰甘油的合成。在200微摩尔氯丙嗪作用下,这伴随着标记前体在磷脂酸中积累平均增加12倍,以及磷脂酸向二酰甘油的转化率降低76%。这些结果表明,磷脂酰胆碱和三酰甘油合成的部分抑制发生在磷脂酸磷酸水解酶水平。在不同浓度氯丙嗪作用下,三酰甘油合成的相对速率大致与磷脂酸向二酰甘油的转化率成正比。当磷脂酸向二酰甘油的转化率较高时,磷脂酰胆碱合成增加,但当氯丙嗪抑制该转化率超过约30%时,磷脂酰胆碱合成相对独立于后者的速率。向肝细胞中添加油酸导致磷脂酸磷酸水解酶从胞质溶胶转移到膜相关区室。氯丙嗪则产生相反作用,无论有无油酸存在,它都会使磷酸水解酶从膜上解离。与肝细胞的膜相关的磷脂酸磷酸水解酶活性与计算得出的[3H]磷脂酸向二酰甘油的转化率之间存在高度显著的相关性。当无细胞制剂与油酸和精胺组合孵育时,氯丙嗪还拮抗磷酸水解酶与微粒体膜的结合。此外,它抑制可溶性磷酸水解酶向用[14C]磷脂酸标记的微粒体膜的转移,从而减少二酰甘油的产生。得出的结论是,氯丙嗪抑制三酰甘油和磷脂酰胆碱合成的部分作用是因为它阻止了可溶性磷脂酸磷酸水解酶与发生甘油脂质合成的膜的相互作用。这反过来又阻止了磷脂酸向二酰甘油的转化。